Last mentioned: Mar 19, 2026
Cycle Completion
Target completion for the first 3-year development cycle under the new model.
First Milestone
Anticipated first-round validation of AI-modeled antidote candidates.
Bidding Window
Expected commencement of bidding for initial U.S. countermeasure contracts.
Consortium Launch
Lunai Bioworks officially establishes the National Chemical Defense Consortium.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to secure up to $1.2 billion in U.S. government countermeasure contracts. The initiative centers on a proprietary three-year AI-driven model designed to accelerate the development of chemical antidotes.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to pursue up to $1.2 billion in U.S. defense countermeasure programs. The initiative utilizes a proprietary 3-year AI development model to drastically accelerate the creation of antidotes for chemical threats.